BioForm Medical, Inc. (BFRM) Tuesday said it has been granted early termination of the waiting period under the Hart-Scott Rodino Antitrust Improvements Act, by the U.S. Federal Trade Commission and the U.S. Department of Justice in connection with the previously announced US$5.45 per share cash tender offer made by Merz GmbH & Co. KGaA and its acquisition subsidiary to purchase all outstanding shares of common stock of BioForm Medical, Inc. The tender offer would expire on February 12, 2010.
For comments and feedback: editorial@rttnews.com